# Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Study · id `cardio:ct-nct04045665` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04045665](<https://clinicaltrials.gov/study/NCT04045665>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04045665

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3200 participants.

## Technical summary

Registry record NCT04045665. Randomized; no masking; primary purpose treatment. Start 2019-12-13 (actual); primary completion 2026-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 3200 participants (planned count; ClinicalTrials.gov record NCT04045665, source copy `cardio:ctgov-nct04045665-2026-06-26`, retrieved 2026-10-26)
- Started: 2019-12-13 (actual) (ClinicalTrials.gov record NCT04045665, source copy `cardio:ctgov-nct04045665-2026-06-26`, retrieved 2026-10-26)
- Primary completion: 2026-08-31 (anticipated) (ClinicalTrials.gov record NCT04045665, source copy `cardio:ctgov-nct04045665-2026-06-26`, retrieved 2026-10-26)
- Completion: 2026-08-31 (anticipated) (ClinicalTrials.gov record NCT04045665, source copy `cardio:ctgov-nct04045665-2026-06-26`, retrieved 2026-10-26)
- Countries: United States; Brazil; Canada; Germany; United Kingdom (ClinicalTrials.gov record NCT04045665, source copy `cardio:ctgov-nct04045665-2026-06-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04045665-2026-06-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Acronym: PACES
- Condition: Atrial Fibrillation
- Condition: Stroke
- Condition: Bleeding
- Intervention (Drug): Antiplatelet-only strategy
- Intervention (Drug): Oral Anticoagulant plus background antiplatelet therapy
- Lead sponsor: Icahn School of Medicine at Mount Sinai
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH
- Collaborator: Vanderbilt University Medical Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Icahn School of Medicine at Mount Sinai (`cardio:org-icahn-school-of-medicine-at-mount-sinai`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)
- Registry lists this organization as a collaborator: Vanderbilt University Medical Center (`cardio:org-vanderbilt-university-medical-center`)

## Provenance

Content hash: e814aaa752531c4c8ede82f354f70656bf3fdb3275f3b1ffa4b9b666aeb3d304
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
